Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases
暂无分享,去创建一个
K. Lassen | R. Lothe | P. W. Eide | A. Nesbakken | K. Kryeziu | A. Sveen | S. H. Moosavi | M. Guren | A. Abildgaard | M. Z. Totland | C. Bergsland | Peter W Eide